The Green Room: A Podcast from Obstetrics & Gynecology August 2024: Obstetrics
Jul 18, 2024
Dr. Marcela Smid, an associate professor and expert in maternal-fetal medicine, dives into pressing concerns in obstetrics. She discusses alarming trends in congenital syphilis and hemorrhage-related deaths, stressing the need for targeted interventions. The conversation highlights innovative strategies in optimizing opioid prescriptions after cesarean sections, balancing effective pain management with a patient-centered approach. Smid's insights into addressing substance use disorders among pregnant patients underscore the importance of collaboration in improving maternal health outcomes.
AI Snips
Chapters
Transcript
Episode notes
Individualized Prescriptions Match Standard Care
- The trial tested an individualized opioid prescription protocol (IOPP) versus a fixed opioid quantity after cesarean delivery using a non-inferiority design.
- Pain at one week postpartum was equivalent between groups, supporting individualized prescribing.
Path From Buprenorphine Waiver To HEAL Trial
- Marcela Smid described how her buprenorphine waiver led her from obesity research into perinatal addiction care.
- That path positioned her to join the MFMU HEAL-funded trial team during COVID-19.
Pick Patient-Centered Primary Outcomes
- Choose clinically meaningful outcomes aligned with funder priorities when designing trials.
- For postoperative pain studies, select patient-centered measures like pain one week after discharge.